BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.2% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUTR
3376
DELISTED
Cutera, Inc.
CUTR
| $50.1K | ﹤0.01% |
2,838
+2,833
| +56,660% | +$44.4K |
|
|
HPR
3377
DELISTED
HighPoint Resources Corporation
HPR
| $49.9K | ﹤0.01% |
+452
| New | +$60.2K |
|
3378
Western New England Bancorp
WNEB
$282M
| $49.9K | ﹤0.01% |
5,407
+4,542
| +525% | +$43.5K |
|
3379
Dianthus Therapeutics
DNTH
$6.21B
| $49.6K | ﹤0.01% |
+188
| New | +$32.4K |
|
|
AAIC
3380
DELISTED
Arlington Asset Investment Corp.
AAIC
| $49.6K | ﹤0.01% |
6,235
+5,145
| +472% | +$42.5K |
|
3381
BlueLinx
BXC
$703M
| $49.5K | ﹤0.01% |
1,859
+1,486
| +398% | +$42.2K |
|
3382
AMES National
ATLO
$283M
| $49.4K | ﹤0.01% |
1,801
+1,517
| +534% | +$40.1K |
|
|
CTLP
3383
DELISTED
Cantaloupe
CTLP
| $49.2K | ﹤0.01% |
11,860
+10,708
| +930% | +$48K |
|
3384
Powell Industries
POWL
$7.62B
| $49.1K | ﹤0.01% |
5,553
+4,308
| +346% | +$42.4K |
|
3385
Southern First Bancshares
SFST
$612M
| $49K | ﹤0.01% |
1,448
+1,244
| +610% | +$44.4K |
|
3386
BayCom
BCML
$342M
| $49K | ﹤0.01% |
2,165
+1,812
| +513% | +$40.3K |
|
3387
Northrim BanCorp
NRIM
$604M
| $48.9K | ﹤0.01% |
5,684
+4,748
| +507% | +$42.8K |
|
3388
Bristow Group
VTOL
$1.37B
| $48.8K | ﹤0.01% |
2,113
+1,768
| +512% | +$37.3K |
|
3389
Covenant Logistics
CVLG
$886M
| $48.7K | ﹤0.01% |
5,136
+3,698
| +257% | +$40.9K |
|
3390
NWPX Infrastructure Inc
NWPX
$1.12B
| $48.6K | ﹤0.01% |
2,025
+1,714
| +551% | +$40.6K |
|
3391
Kiniksa Pharmaceuticals
KNSA
$6.09B
| $48.5K | ﹤0.01% |
2,685
+2,467
| +1,132% | +$47.7K |
|
3392
Citi Trends
CTRN
$629M
| $48.4K | ﹤0.01% |
2,506
+876
| +54% | +$18K |
|
3393
Commercial Vehicle Group
CVGI
$130M
| $48.3K | ﹤0.01% |
6,295
+6,285
| +62,850% | +$47.2K |
|
|
TTSH
3394
DELISTED
Tile Shop Holdings
TTSH
| $48.3K | ﹤0.01% |
8,529
+7,804
| +1,076% | +$50.7K |
|
|
YELL
3395
DELISTED
Yellow Corporation Common Stock
YELL
| $48.3K | ﹤0.01% |
7,215
+3,335
| +86% | +$21.5K |
|
3396
Goldgroup Mining Inc.
GORO
$212M
| $48.1K | ﹤0.01% |
12,252
+10,153
| +484% | +$43.9K |
|
|
FRBK
3397
DELISTED
Republic First Bancorp Inc
FRBK
| $48.1K | ﹤0.01% |
9,167
+7,967
| +664% | +$48.9K |
|
|
SYRS
3398
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $48.1K | ﹤0.01% |
+526
| New | +$36.6K |
|
3399
Applied Optoelectronics
AAOI
$11.6B
| $48K | ﹤0.01% |
3,938
-11,083
| -74% | -$167K |
|
3400
Abeona Therapeutics
ABEO
$357M
| $47.9K | ﹤0.01% |
260
+259
| +25,900% | +$46.3K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.